The Fed is the most divided it’s been in more than six years

The Fed is the most divided it’s been in more than six years


Federal Reserve Governor Stephen Miran speaks with CNBC during the Invest i America Forum on Oct. 15, 2025.

CNBC

There were three dissenters from the Federal Reserve’s decision to lower the federal funds rate by a quarter percentage point on Wednesday, making it the most divisive the central bank has been in more than a decade.

Chicago Fed President Austan Goolsbee joined Kansas City Fed President Jeffrey Schmid in voting for no decrease. The newest member, Federal Reserve Governor Stephen Miran, again called for a half-point cut. It is the third dissent in a row for Miran, who called for a half-point rate cut in both the October and September meetings. Schmid also called for no decrease in October.

The last time there were three dissents during a Fed meeting was in September 2019.

In addition, there were four other so-called soft dissents by nonvoting meeting participants. The policymakers submitted a forecast for interest rates to have ended the year at the previous level of 3.75 percent to 4 percent.

“‘Hard dissents’ from voting members as well as the ‘soft dissents’ seen in the dot plot highlight the Fed’s hawkish bloc, and the return of ‘extent and timing’ language to the statement regarding future policy decisions was likely done to appease them,” said Kay Haigh, global co-head of fixed income and liquidity solutions in Goldman Sachs Asset Management.

“While this leaves the door open to future cuts, labor market weakness will have to clear a high bar,” she added.

However, Christopher Rupkey, chief economist at FWDBONDS, said that the dissents against the rate cuts may not necessarily offer a window into next year’s moves.

“The dissents ruled against a faster pace of rate cuts today, but the winds of change are in the air,” he said. “A new Fed Chair in 2026, and perhaps many more new Fed officials, means more interest rate cuts are coming next year as rate cuts are big on the Trump 2.0 economic agenda even if not listed explicitly, if for nothing else but to weigh against the slowing economy due to the import tariffs uncertainty.”

— CNBC’s Jeff Cox contributed reporting.

Correction: The last time there were three dissents during a Fed meeting was in September 2019. An earlier version misstated the month and year.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More